Phreesia (PHR) stock in plain English
Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.
Change shown by the quote provider. Data may be delayed.
What does Phreesia (PHR) do?
Phreesia Inc (PHR) is a U.S.-listed company in Healthcare (Health Information Services). What it does: Sells digital patient intake software, check-in pads, and payment collection systems to healthcare providers. It automates patient check-in and payment collection across thousands of American medical practices. It is worth $736.78M on the market and sold $508.12M over the last year.
- Market cap
- $736.78M
- P/E ratio
- 70.3×
- Annual sales
- $508.12M
- Sector
- Healthcare
- Industry
- Health Information Services
- Brief updated
- Nov 17, 2026
Brands and businesses behind PHR
- MediFind: Finds specialized doctors and clinical trials for patients, generating revenue from pharmaceutical company sponsorships.
- Insignia Health: Licenses patient engagement assessment surveys and analytics software to healthcare organizations and insurers.
PHR’s flags, in plain English
Each flag is a number from Phreesia’s reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 17, 2026.
Still Climbing
Sales up 26.5% a year over 5 years. Sales are higher than a year ago. Growth does not guarantee profit, so look at the margins too.
Earnings Jumping
Profits up 627.8% this year. Profit per share is growing fast this year. One year does not make a trend, so check whether sales grew too.
Growth vs Price
The price looks reasonable for how fast it is growing. The price looks reasonable for how fast its profits are growing.
Priced for Perfection
Priced at 70.3 times its yearly profit, so a lot of growth is already expected. The share price already assumes strong results, so news that is merely good can still send it down.
2 more green flags and 1 more risk note open with the free trial. Try it free for 7 days.
Questions about PHR
How big is Phreesia?
Phreesia’s market cap is $736.78M: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $508.12M: what customers paid the company over the last year, before any costs.
What is PHR’s P/E ratio?
PHR’s P/E ratio is 70.3×. Investors pay about 70.3 dollars for each dollar of the company’s yearly profit. A low number can mean a bargain or a problem, so read it next to the flags.
What could go wrong with PHR?
A substantial portion of total revenue relies on digital advertising budgets from pharmaceutical and life sciences companies. That is one risk on Phreesia’s card. Its first risk flag is Priced for Perfection, explained above. The card holds 1 more risk note for trial accounts. A flag reads what the company reported. It does not predict the price.
Where do these numbers come from?
From Phreesia’s own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. PHR’s filings on SEC.gov. The Margin Monkey is research, not advice.
